Table of Contents

2017 Month : July Volume : 6 Issue : 53 Page : 3992-3995

CLINICAL EFFICACY OF TACROLIMUS IN INFANTILE HAEMANGIOMA.

Loknath Ghoshal1, Arun Achar2

1Assistant Professor, Department of Dermatology, NRS Medical College, Kolkata, West Bengal.
2Associate Professor, Department of Dermatology, NRS Medical College, Kolkata, West Bengal.

References :

1

Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005;22(5):383-406.

CrossRef | Google Scholar | PubMed
2

Hasan Q, Tan ST, Gush J, et al. Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics 2000;105(1 Pt 1):117-20.

CrossRef | Google Scholar | PubMed
3

Leaute-Labreze C, Prey S, Ezzedine K. Infantile haemangioma. Part II. Risks, complications and treatment. J Eur Acad Dermatol Venereol 2011;25(11):1254-60.

CrossRef | Google Scholar | PubMed
4

Painter SL, Hildebrand GD. Review of topical beta blockers as treatment for infantile hemangiomas. Surv Ophthalmol 2016;61(1):51-8.

CrossRef | Google Scholar | PubMed
5

Sagi L, Zvulunov A, Lapidoth M, et al. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases. Dermatology 2014;228(2):136-44.

CrossRef | Google Scholar | PubMed
6

Couto JA, Greene AK. Management of problematic infantile hemangioma using intralesional triamcinolone: efficacy and safety in 100 infants. J Plast Reconstr Aesthet Surg 2014;67(11):1469-74.

CrossRef | Google Scholar | PubMed
7

Garzon MC, Lucky AW, Hawrot A, et al. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am AcadDermatol 2005;52(2):281-6.

CrossRef | Google Scholar | PubMed
8

Qiu Y, Ma G, Yang J, et al. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study. Clin Exp Dermatol 2013;38(8):845-50.

CrossRef | Google Scholar | PubMed
9

Kunzi-Rapp K. Topical propranolol therapy for infantile hemangiomas. Pediatr Dermatol 2012;29(2): 154-9.

CrossRef | Google Scholar | PubMed
10

McMahon P, Oza V, Frieden IJ. Topical timolol for infantile hemangiomas: putting a note of caution in ‘cautiously optimistic’. Pediatr Dermatol 2012;29(1): 127-30.

CrossRef | Google Scholar | PubMed
11

Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol 2012;29(1):28-31.

CrossRef | Google Scholar | PubMed
12

Khunger N, Pahwa M. Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome. Br J Dermatol 2011;164(4):886-8.

CrossRef | Google Scholar | PubMed
13

Sun ZJ, Zhao YF, Zhang WF. Immune response: a possible role in the pathophysiology of hemangioma. Med Hypotheses 2007;68(2):353-5.

CrossRef | Google Scholar | PubMed
14

Hazen PG, Carney JF, Engstrom CW, et al. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream. Pediatr Dermatol 2005;22(3):254-6.

CrossRef | Google Scholar | PubMed
15

Jia J, Zhao YF, Zhao JH. Potential roles of allograft inflammatory factor-1 in the pathogenesis of hemangiomas. Med Hypotheses 2007;68(2):288-90.

CrossRef | Google Scholar | PubMed
16

Lazaridou E, Giannopoulou C, Apalla Z, et al. Calcineurin inhibitors in the treatment of cutaneous infantile haemangiomas. J Eur Acad Dermatol Venereol 2010;24(5):611-24.